Alemtuzumab for Refractory Primary Systemic Vasculitis Alemtuzumab for Refractory Primary Systemic Vasculitis

Alemtuzumab may provide another safe and effective treatment option for primary systemic vasculitis patients who failed to respond to other therapies.Arthritis Research & Therapy
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news